WE SUPPORT
HEALTHY COMMUNITIES
Macedonia Community Development Corporation (MCDC) understands the importance of health and well-being and the role good health plays to make communities vibrant and strong. Our health and well-being program goals are to provide health care information to a wide range of communities.
HEALTH PROGRAMS
As the administration director, Matsuda is responsible for general agency administrative functions such as marketing, communications, personnel management and compliance. Prior to starting On Board in 2018, her own business and community consulting firm in 2018, Pegi Matsuda had extensive experience in corporate and small business operations, administration, management and leadership in numerous industries. She was also the first director of economic and community development for a global telecommunications company with operations in the western United States. As director, she created programs that helped corporate operations identify economic and community needs and led the companyβs first regional βcommunity needs assessmentβ to better understand communities and identified opportunities to help thrive and grow. She also has experience working with health care community benefit programs which help hospitals better understand communities. Her first experience in the Watts community was serving for five years as a volunteer with the LA Watts Summer Games. As a student of cultural art in college, Matsuda has made many trips to the Watts Towers to study its structure and preservation practices.
Sheβs a highly recognize community leader and has received a variety of recognition from local business and community organizations. She has a MS in Organizational Leadership from Woodbury University and a BS in Human Relations and Organizational Behavior from the University of San Francisco. She also holds the designation as a Certified Fund Raising Executive (βCFREβ) from CFRE International and is one of only 8,000 global fundraising executives who has undergone the rigorous training to obtain the certification.

CAR T CELL THERAPY
Promoting awareness and treatment options for those impacted by lymphoma and multiple myeloma are featured workshops this year.
Despite transformational clinical impact, only 10-20% of patients that are eligible for CAR T are receiving one. Within this statistic, there are major disparities that further health inequities across race and socioeconomic status. Broadening access to this important modality will also be critical to long-term innovation and investment in the field
Despite the first cell therapy launching in 2017 in the United States and established efficacy and safety in heme malignancies, uptake of the class has been slow. Class share within multiple myeloma and lymphoma has failed to increase beyond 10 β 20% (dependent on disease and line of therapy), meaning many eligible patients are missing out on a one-time, impactful treatment option. This is even more stark for patients that are non-white, well-educated or socio-economically advantaged.
CAR T CELL THERAPY RESOURCES
For more information on CAR T Cell Therapy and other cancer treatment therapies, please visit these websites:
Health Tree Foundation Mylenoma Awareness Month (March)
International Myeloma Foundation (IMF) Celebrates Myeloma Milestones for 2025 Action Month
Leukemia & Lymphoma Society: March Is Myeloma Awareness Month
Cell Therapy 360: Your Partner Throughout the CAR T Cell Therapy Treatment Journey
Understanding CAR T-Cell Therapy: A Breakthrough in Cancer Treatment (short)
What is CAR T Cell Therapy? What Cancer Patients Need to Know! (short)
Lymphoma: Overview of Chimeric Antigen Receptor (CAR T Cells)
Symptoms of Multiple Myeloma Cancer and Early Warning Signs (short)
IMFMyeloma: Itβs Getting Worse for People of Color (short)
Bristol Myers Squibb Patient Stories: Meet Eric
Bristol Myers Squibb Survivorship Today: Being resilient and embracing new dreams
SPONSORS